NCT05253755View on ClinicalTrials.gov

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

September 9, 2022

Study Completion Date

September 9, 2022

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

DBI-001

Topical application of DBI-001 gel on skin affected with atopic dermatitis.

BIOLOGICAL

Aqueous gel

Topical application of aqueous gel on skin affected with atopic dermatitis.

Trial Locations (3)

78759

DermResearch, Inc., Austin

85255

Investigate MD, LLC, Scottsdale

98012

North Sound Dermatology, Mill Creek

Sponsors

Lead Sponsor

DermBiont, Inc.
All Listed Sponsors
collaborator

Derm Research, PLLC

OTHER

collaborator

Northsoundderm

OTHER

collaborator

Clear Dermatology

OTHER

lead

DermBiont, Inc.

INDUSTRY